Skip to main content

Find Clinical Trials

Home
Conditions
Antiphospholipid Syndrome

Clinical trial condition

Antiphospholipid Syndrome

Explore clinical trials studying Antiphospholipid Syndrome. Study availability and eligibility vary by location and protocol.

53 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Antiphospholipid Syndrome trial results

Completed

Medium-term Follow-up of Patients With Obstetric Antiphospholipid Syndrome: MRI Study of White Matter

NCT03600636

Conditions: Antiphospholipid Syndrome, Autoimmune Diseases, Immune System Diseases
Locations: CHU Nimes Nîmes, France

View Trial Details

Completed

Evaluation of the Incidence of Cancer in the Follow-up of Women With 3 Consecutive Embryonic Demises Before 10 Weeks or 1 Fetal Death, According to Their Thrombophilia Status, With a Special Focus on Women With an Obstetric Antiphospholipid Symdrome (oAPS)

NCT03969498

Conditions: Antiphospholipid Syndrome, Autoimmune Diseases, Cancer, +3 more
Locations: CHUNimes Nîmes, France

View Trial Details

Completed

The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations

NCT02855047

Conditions: Antiphospholipid Syndrome, Autoimmune Diseases, Immune System Diseases
Locations: CHU de Nîmes - Hôpital Universitaire Carémea Nîmes, France

View Trial Details

Completed

Assessment of the Prevalence of Major Psychiatric Disorders in a Cohort of Women With Clinical Criteria Corresponding to Pure, Abortive-form, Obstetrical, Antiphospholipid Syndrome

NCT02833194

Conditions: Antiphospholipid Syndrome, Autoimmune Diseases, Factor V Leiden Thrombophilia, +2 more
Locations: CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes, France

View Trial Details

Completed

Effect of Injectable Anticoagulants on Research for a Circulating Lupus-type Anticoagulant

NCT05416190

Conditions: Anticoagulant Drugs, Antiphospholipid Syndrome, Autoimmune Diseases, +1 more
Locations: CHU clermont-ferrand Clermont-Ferrand, France

View Trial Details

Completed

Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome

NCT02295475

Conditions: Antiphospholipid Syndrome, Autoimmune Diseases, Cardiovascular Diseases, +4 more
Locations: The James Comprehensive Cancer Center Columbus, Ohio, United States

Intermountain Medical Center Murray, Utah, United States

View Trial Details

Completed

Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX)

NCT03994302

Conditions: Adverse Drug Event, Antiphospholipid Syndrome, Autoimmune Diseases, +5 more
Locations: AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM Paris, France

View Trial Details

Completed

Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome

NCT05195372

Conditions: Antiphospholipid Syndrome, Arterial Thromboembolism, Autoimmune Diseases, +8 more
Locations: Edelgard Lindhoff-Last Frankfurt am Main, Hesse, Germany

View Trial Details

Completed

Prospective Observational Study to Evaluate a Possible Change in APS Antibody Profiles After COVID-19 Infection or Vaccination

NCT05313048

Conditions: Antiphospholipid Syndrome, Autoimmune Diseases, COVID-19, +14 more
Locations: Cardioangiology Center Bethanien (CCB) Frankfurt am Main, Germany

View Trial Details

Completed

Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.

NCT00180817

Conditions: Antiphospholipid Syndrome, Autoimmune Diseases, Immune System Diseases
Locations: St. Mary's Hospital London, United Kingdom

View Trial Details